Expression of myeloperoxidase and gene mutations in AML patients with normal karyotype: double CEBPA mutations are associated with high percentage ... View Full Text


Ontology type: schema:ScholarlyArticle      Open Access: True


Article Info

DATE

2011-07

AUTHORS

Shinya Tominaga-Sato, Hideki Tsushima, Koji Ando, Hidehiro Itonaga, Yoshitaka Imaizumi, Daisuke Imanishi, Masako Iwanaga, Jun Taguchi, Takuya Fukushima, Shinichiro Yoshida, Tomoko Hata, Yukiyoshi Moriuchi, Kazutaka Kuriyama, Hiroyuki Mano, Masao Tomonaga, Yasushi Miyazaki

ABSTRACT

The percentage of myeloperoxidase (MPO)-positive blast cells is a simple and highly significant prognostic factor in AML patients. It has been reported that the high MPO group (MPO-H), in which >50% of blasts are MPO activity positive, is associated with favorable karyotypes, while the low MPO group (≤50% of blasts are MPO activity positive, MPO-L) is associated with adverse karyotypes. The MPO-H group shows better survival even when restricted to patients belonging to the intermediate chromosomal risk group or those with a normal karyotype. It has recently been shown that genotypes defined by the mutational status of NPM1, FLT3, and CEBPA are associated with treatment outcome in patients with cytogenetically normal AML. In this study, we aimed to evaluate the relationship between MPO positivity and gene mutations found in normal karyotypes. Sixty AML patients with normal karyotypes were included in this study. Blast cell MPO positivity was assessed in bone marrow smears stained for MPO. Associated genetic lesions (the NPM1, FLT3-ITD, and CEBPA mutations) were studied using nucleotide sequencing. Thirty-two patients were in the MPO-L group, and 28 patients in the MPO-H group. FLT3-ITD was found in 11 patients (18.3%), NPM1 mutations were found in 19 patients (31.7%), and CEBPA mutations were found in 11 patients (18.3%). In patients with CEBPA mutations, the carrying two simultaneous mutations (CEBPA (double-mut)) was associated with high MPO expression, while the mutant NPM1 without FLT3-ITD genotype was not associated with MPO activity. Both higher MPO expression and the CEBPA (double-mut) genotype appeared to be associated with improved overall survival after intensive chemotherapy. Further studies are required to determine the importance of blast MPO activity as a prognostic factor, especially in CEBPA wild-type patients with a normal karyotype. More... »

PAGES

81-89

Identifiers

URI

http://scigraph.springernature.com/pub.10.1007/s12185-011-0883-y

DOI

http://dx.doi.org/10.1007/s12185-011-0883-y

DIMENSIONS

https://app.dimensions.ai/details/publication/pub.1024091448

PUBMED

https://www.ncbi.nlm.nih.gov/pubmed/21674360


Indexing Status Check whether this publication has been indexed by Scopus and Web Of Science using the SN Indexing Status Tool
Incoming Citations Browse incoming citations for this publication using opencitations.net

JSON-LD is the canonical representation for SciGraph data.

TIP: You can open this SciGraph record using an external JSON-LD service: JSON-LD Playground Google SDTT

[
  {
    "@context": "https://springernature.github.io/scigraph/jsonld/sgcontext.json", 
    "about": [
      {
        "id": "http://purl.org/au-research/vocabulary/anzsrc-for/2008/1112", 
        "inDefinedTermSet": "http://purl.org/au-research/vocabulary/anzsrc-for/2008/", 
        "name": "Oncology and Carcinogenesis", 
        "type": "DefinedTerm"
      }, 
      {
        "id": "http://purl.org/au-research/vocabulary/anzsrc-for/2008/11", 
        "inDefinedTermSet": "http://purl.org/au-research/vocabulary/anzsrc-for/2008/", 
        "name": "Medical and Health Sciences", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Blast Crisis", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "CCAAT-Enhancer-Binding Proteins", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Gene Expression Regulation, Leukemic", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Genes, Neoplasm", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Humans", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Karyotype", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Leukemia, Myeloid, Acute", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Mutation", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Nuclear Proteins", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Peroxidase", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Survival Rate", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "fms-Like Tyrosine Kinase 3", 
        "type": "DefinedTerm"
      }
    ], 
    "author": [
      {
        "affiliation": {
          "alternateName": "Nagasaki University", 
          "id": "https://www.grid.ac/institutes/grid.174567.6", 
          "name": [
            "Department of Hematology and Molecular Medicine Unit, Atomic Bomb Disease Institute, Nagasaki University Graduate School of Biomedical Sciences, Nagasaki, Nagasaki, Japan"
          ], 
          "type": "Organization"
        }, 
        "familyName": "Tominaga-Sato", 
        "givenName": "Shinya", 
        "id": "sg:person.01260160370.57", 
        "sameAs": [
          "https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01260160370.57"
        ], 
        "type": "Person"
      }, 
      {
        "affiliation": {
          "alternateName": "Nagasaki University Hospital", 
          "id": "https://www.grid.ac/institutes/grid.411873.8", 
          "name": [
            "Department of Hematology, Nagasaki University Hospital, 1-7-1 Sakamoto, 852-8501, Nagasaki, Japan"
          ], 
          "type": "Organization"
        }, 
        "familyName": "Tsushima", 
        "givenName": "Hideki", 
        "id": "sg:person.0632143365.98", 
        "sameAs": [
          "https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.0632143365.98"
        ], 
        "type": "Person"
      }, 
      {
        "affiliation": {
          "name": [
            "Department of Internal Medicine, Nagasaki National Medical Center, Ohmura, Nagasaki, Japan"
          ], 
          "type": "Organization"
        }, 
        "familyName": "Ando", 
        "givenName": "Koji", 
        "id": "sg:person.0664421234.93", 
        "sameAs": [
          "https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.0664421234.93"
        ], 
        "type": "Person"
      }, 
      {
        "affiliation": {
          "alternateName": "Nagasaki University", 
          "id": "https://www.grid.ac/institutes/grid.174567.6", 
          "name": [
            "Department of Hematology and Molecular Medicine Unit, Atomic Bomb Disease Institute, Nagasaki University Graduate School of Biomedical Sciences, Nagasaki, Nagasaki, Japan"
          ], 
          "type": "Organization"
        }, 
        "familyName": "Itonaga", 
        "givenName": "Hidehiro", 
        "id": "sg:person.01221607161.35", 
        "sameAs": [
          "https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01221607161.35"
        ], 
        "type": "Person"
      }, 
      {
        "affiliation": {
          "alternateName": "Nagasaki University Hospital", 
          "id": "https://www.grid.ac/institutes/grid.411873.8", 
          "name": [
            "Department of Hematology, Nagasaki University Hospital, 1-7-1 Sakamoto, 852-8501, Nagasaki, Japan"
          ], 
          "type": "Organization"
        }, 
        "familyName": "Imaizumi", 
        "givenName": "Yoshitaka", 
        "id": "sg:person.0700256565.36", 
        "sameAs": [
          "https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.0700256565.36"
        ], 
        "type": "Person"
      }, 
      {
        "affiliation": {
          "alternateName": "Nagasaki University Hospital", 
          "id": "https://www.grid.ac/institutes/grid.411873.8", 
          "name": [
            "Department of Hematology, Nagasaki University Hospital, 1-7-1 Sakamoto, 852-8501, Nagasaki, Japan"
          ], 
          "type": "Organization"
        }, 
        "familyName": "Imanishi", 
        "givenName": "Daisuke", 
        "id": "sg:person.0673127034.00", 
        "sameAs": [
          "https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.0673127034.00"
        ], 
        "type": "Person"
      }, 
      {
        "affiliation": {
          "alternateName": "Nagasaki University", 
          "id": "https://www.grid.ac/institutes/grid.174567.6", 
          "name": [
            "Department of Hematology and Molecular Medicine Unit, Atomic Bomb Disease Institute, Nagasaki University Graduate School of Biomedical Sciences, Nagasaki, Nagasaki, Japan"
          ], 
          "type": "Organization"
        }, 
        "familyName": "Iwanaga", 
        "givenName": "Masako", 
        "id": "sg:person.0651002670.18", 
        "sameAs": [
          "https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.0651002670.18"
        ], 
        "type": "Person"
      }, 
      {
        "affiliation": {
          "alternateName": "Nagasaki University", 
          "id": "https://www.grid.ac/institutes/grid.174567.6", 
          "name": [
            "Department of Hematology and Molecular Medicine Unit, Atomic Bomb Disease Institute, Nagasaki University Graduate School of Biomedical Sciences, Nagasaki, Nagasaki, Japan"
          ], 
          "type": "Organization"
        }, 
        "familyName": "Taguchi", 
        "givenName": "Jun", 
        "id": "sg:person.01354366606.35", 
        "sameAs": [
          "https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01354366606.35"
        ], 
        "type": "Person"
      }, 
      {
        "affiliation": {
          "alternateName": "Nagasaki University Hospital", 
          "id": "https://www.grid.ac/institutes/grid.411873.8", 
          "name": [
            "Department of Hematology, Nagasaki University Hospital, 1-7-1 Sakamoto, 852-8501, Nagasaki, Japan"
          ], 
          "type": "Organization"
        }, 
        "familyName": "Fukushima", 
        "givenName": "Takuya", 
        "id": "sg:person.01231324634.52", 
        "sameAs": [
          "https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01231324634.52"
        ], 
        "type": "Person"
      }, 
      {
        "affiliation": {
          "name": [
            "Department of Internal Medicine, Nagasaki National Medical Center, Ohmura, Nagasaki, Japan"
          ], 
          "type": "Organization"
        }, 
        "familyName": "Yoshida", 
        "givenName": "Shinichiro", 
        "id": "sg:person.014677655512.53", 
        "sameAs": [
          "https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.014677655512.53"
        ], 
        "type": "Person"
      }, 
      {
        "affiliation": {
          "alternateName": "Nagasaki University Hospital", 
          "id": "https://www.grid.ac/institutes/grid.411873.8", 
          "name": [
            "Department of Hematology, Nagasaki University Hospital, 1-7-1 Sakamoto, 852-8501, Nagasaki, Japan"
          ], 
          "type": "Organization"
        }, 
        "familyName": "Hata", 
        "givenName": "Tomoko", 
        "id": "sg:person.01014505165.38", 
        "sameAs": [
          "https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01014505165.38"
        ], 
        "type": "Person"
      }, 
      {
        "affiliation": {
          "alternateName": "Sasebo City General Hospital", 
          "id": "https://www.grid.ac/institutes/grid.415288.2", 
          "name": [
            "Division of Hematology, Sasebo City General Hospital, Sasebo, Nagasaki, Japan"
          ], 
          "type": "Organization"
        }, 
        "familyName": "Moriuchi", 
        "givenName": "Yukiyoshi", 
        "id": "sg:person.01227410302.05", 
        "sameAs": [
          "https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01227410302.05"
        ], 
        "type": "Person"
      }, 
      {
        "affiliation": {
          "alternateName": "University of the Ryukyus", 
          "id": "https://www.grid.ac/institutes/grid.267625.2", 
          "name": [
            "School of Health Sciences, University of the Ryukyus, Okinawa, Nishihara, Japan"
          ], 
          "type": "Organization"
        }, 
        "familyName": "Kuriyama", 
        "givenName": "Kazutaka", 
        "id": "sg:person.01106224616.45", 
        "sameAs": [
          "https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01106224616.45"
        ], 
        "type": "Person"
      }, 
      {
        "affiliation": {
          "alternateName": "Jichi Medical University", 
          "id": "https://www.grid.ac/institutes/grid.410804.9", 
          "name": [
            "Division of Functional Genomics, Jichi Medical University, Shimotsuke, Tochigi, Japan"
          ], 
          "type": "Organization"
        }, 
        "familyName": "Mano", 
        "givenName": "Hiroyuki", 
        "id": "sg:person.0776410617.00", 
        "sameAs": [
          "https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.0776410617.00"
        ], 
        "type": "Person"
      }, 
      {
        "affiliation": {
          "name": [
            "Department of Hematology, Japanese Red-Cross Nagasaki Atomic Bomb Hospital, Nagasaki, Nagasaki, Japan"
          ], 
          "type": "Organization"
        }, 
        "familyName": "Tomonaga", 
        "givenName": "Masao", 
        "id": "sg:person.0740307166.37", 
        "sameAs": [
          "https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.0740307166.37"
        ], 
        "type": "Person"
      }, 
      {
        "affiliation": {
          "alternateName": "Nagasaki University", 
          "id": "https://www.grid.ac/institutes/grid.174567.6", 
          "name": [
            "Department of Hematology and Molecular Medicine Unit, Atomic Bomb Disease Institute, Nagasaki University Graduate School of Biomedical Sciences, Nagasaki, Nagasaki, Japan"
          ], 
          "type": "Organization"
        }, 
        "familyName": "Miyazaki", 
        "givenName": "Yasushi", 
        "id": "sg:person.012267426162.55", 
        "sameAs": [
          "https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.012267426162.55"
        ], 
        "type": "Person"
      }
    ], 
    "citation": [
      {
        "id": "sg:pub.10.1007/s12185-009-0480-5", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1000301266", 
          "https://doi.org/10.1007/s12185-009-0480-5"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "sg:pub.10.1007/s12185-009-0480-5", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1000301266", 
          "https://doi.org/10.1007/s12185-009-0480-5"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1016/s0145-2126(98)00105-2", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1000694444"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1016/j.leukres.2005.12.012", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1006793816"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1182/blood-2002-03-0990", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1008614109"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "sg:pub.10.1038/sj.leu.2402465", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1010409391", 
          "https://doi.org/10.1038/sj.leu.2402465"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "sg:pub.10.1038/sj.leu.2402465", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1010409391", 
          "https://doi.org/10.1038/sj.leu.2402465"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1056/nejmoa074306", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1013947506"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "sg:pub.10.1038/sj.leu.2403010", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1014114804", 
          "https://doi.org/10.1038/sj.leu.2403010"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "sg:pub.10.1038/sj.leu.2403010", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1014114804", 
          "https://doi.org/10.1038/sj.leu.2403010"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "sg:pub.10.1038/modpathol.3800168", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1016213372", 
          "https://doi.org/10.1038/modpathol.3800168"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "sg:pub.10.1038/modpathol.3800168", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1016213372", 
          "https://doi.org/10.1038/modpathol.3800168"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1056/nejmoa041974", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1020502159"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1016/j.bbrc.2008.04.065", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1021924180"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1182/blood-2005-05-2174", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1022325658"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1182/blood-2010-02-270181", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1022326233"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1128/mcb.15.4.1974", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1028775369"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1182/blood-2010-03-273243", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1030943868"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1182/blood-2008-09-179895", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1033351081"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1182/blood-2005-06-2248", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1036438078"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1002/cncr.21493", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1039706671"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1002/cncr.21493", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1039706671"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1200/jco.2008.21.6010", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1042759768"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "sg:pub.10.1007/s12185-010-0573-1", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1047743690", 
          "https://doi.org/10.1007/s12185-010-0573-1"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "sg:pub.10.1007/s12185-010-0573-1", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1047743690", 
          "https://doi.org/10.1007/s12185-010-0573-1"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "sg:pub.10.1038/sj.leu.2403838", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1049352910", 
          "https://doi.org/10.1038/sj.leu.2403838"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "sg:pub.10.1038/sj.leu.2403838", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1049352910", 
          "https://doi.org/10.1038/sj.leu.2403838"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1182/blood.v99.4.1332", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1052118597"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "sg:pub.10.1038/leu.2008.8", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1053611084", 
          "https://doi.org/10.1038/leu.2008.8"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1080/01621459.1958.10501452", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1058299418"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.7326/0003-4819-103-4-620", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1073690404"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://app.dimensions.ai/details/publication/pub.1074362860", 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://app.dimensions.ai/details/publication/pub.1074507000", 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://app.dimensions.ai/details/publication/pub.1074525596", 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://app.dimensions.ai/details/publication/pub.1082668270", 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://app.dimensions.ai/details/publication/pub.1083319627", 
        "type": "CreativeWork"
      }
    ], 
    "datePublished": "2011-07", 
    "datePublishedReg": "2011-07-01", 
    "description": "The percentage of myeloperoxidase (MPO)-positive blast cells is a simple and highly significant prognostic factor in AML patients. It has been reported that the high MPO group (MPO-H), in which >50% of blasts are MPO activity positive, is associated with favorable karyotypes, while the low MPO group (\u226450% of blasts are MPO activity positive, MPO-L) is associated with adverse karyotypes. The MPO-H group shows better survival even when restricted to patients belonging to the intermediate chromosomal risk group or those with a normal karyotype. It has recently been shown that genotypes defined by the mutational status of NPM1, FLT3, and CEBPA are associated with treatment outcome in patients with cytogenetically normal AML. In this study, we aimed to evaluate the relationship between MPO positivity and gene mutations found in normal karyotypes. Sixty AML patients with normal karyotypes were included in this study. Blast cell MPO positivity was assessed in bone marrow smears stained for MPO. Associated genetic lesions (the NPM1, FLT3-ITD, and CEBPA mutations) were studied using nucleotide sequencing. Thirty-two patients were in the MPO-L group, and 28 patients in the MPO-H group. FLT3-ITD was found in 11 patients (18.3%), NPM1 mutations were found in 19 patients (31.7%), and CEBPA mutations were found in 11 patients (18.3%). In patients with CEBPA mutations, the carrying two simultaneous mutations (CEBPA (double-mut)) was associated with high MPO expression, while the mutant NPM1 without FLT3-ITD genotype was not associated with MPO activity. Both higher MPO expression and the CEBPA (double-mut) genotype appeared to be associated with improved overall survival after intensive chemotherapy. Further studies are required to determine the importance of blast MPO activity as a prognostic factor, especially in CEBPA wild-type patients with a normal karyotype.", 
    "genre": "research_article", 
    "id": "sg:pub.10.1007/s12185-011-0883-y", 
    "inLanguage": [
      "en"
    ], 
    "isAccessibleForFree": true, 
    "isFundedItemOf": [
      {
        "id": "sg:grant.6040812", 
        "type": "MonetaryGrant"
      }
    ], 
    "isPartOf": [
      {
        "id": "sg:journal.1076985", 
        "issn": [
          "0925-5710", 
          "1865-3774"
        ], 
        "name": "International Journal of Hematology", 
        "type": "Periodical"
      }, 
      {
        "issueNumber": "1", 
        "type": "PublicationIssue"
      }, 
      {
        "type": "PublicationVolume", 
        "volumeNumber": "94"
      }
    ], 
    "name": "Expression of myeloperoxidase and gene mutations in AML patients with normal karyotype: double CEBPA mutations are associated with high percentage of MPO positivity in leukemic blasts", 
    "pagination": "81-89", 
    "productId": [
      {
        "name": "readcube_id", 
        "type": "PropertyValue", 
        "value": [
          "72c6dff3fa877e8c622cbbaecdcc5f7143bcb5731d4b4c5c52b98d7fea2d0606"
        ]
      }, 
      {
        "name": "pubmed_id", 
        "type": "PropertyValue", 
        "value": [
          "21674360"
        ]
      }, 
      {
        "name": "nlm_unique_id", 
        "type": "PropertyValue", 
        "value": [
          "9111627"
        ]
      }, 
      {
        "name": "doi", 
        "type": "PropertyValue", 
        "value": [
          "10.1007/s12185-011-0883-y"
        ]
      }, 
      {
        "name": "dimensions_id", 
        "type": "PropertyValue", 
        "value": [
          "pub.1024091448"
        ]
      }
    ], 
    "sameAs": [
      "https://doi.org/10.1007/s12185-011-0883-y", 
      "https://app.dimensions.ai/details/publication/pub.1024091448"
    ], 
    "sdDataset": "articles", 
    "sdDatePublished": "2019-04-10T15:54", 
    "sdLicense": "https://scigraph.springernature.com/explorer/license/", 
    "sdPublisher": {
      "name": "Springer Nature - SN SciGraph project", 
      "type": "Organization"
    }, 
    "sdSource": "s3://com-uberresearch-data-dimensions-target-20181106-alternative/cleanup/v134/2549eaecd7973599484d7c17b260dba0a4ecb94b/merge/v9/a6c9fde33151104705d4d7ff012ea9563521a3ce/jats-lookup/v90/0000000001_0000000264/records_8664_00000522.jsonl", 
    "type": "ScholarlyArticle", 
    "url": "http://link.springer.com/10.1007%2Fs12185-011-0883-y"
  }
]
 

Download the RDF metadata as:  json-ld nt turtle xml License info

HOW TO GET THIS DATA PROGRAMMATICALLY:

JSON-LD is a popular format for linked data which is fully compatible with JSON.

curl -H 'Accept: application/ld+json' 'https://scigraph.springernature.com/pub.10.1007/s12185-011-0883-y'

N-Triples is a line-based linked data format ideal for batch operations.

curl -H 'Accept: application/n-triples' 'https://scigraph.springernature.com/pub.10.1007/s12185-011-0883-y'

Turtle is a human-readable linked data format.

curl -H 'Accept: text/turtle' 'https://scigraph.springernature.com/pub.10.1007/s12185-011-0883-y'

RDF/XML is a standard XML format for linked data.

curl -H 'Accept: application/rdf+xml' 'https://scigraph.springernature.com/pub.10.1007/s12185-011-0883-y'


 

This table displays all metadata directly associated to this object as RDF triples.

331 TRIPLES      21 PREDICATES      70 URIs      33 LITERALS      21 BLANK NODES

Subject Predicate Object
1 sg:pub.10.1007/s12185-011-0883-y schema:about N4478a5b054bd4f42b37c47b5e06131fb
2 N6089f119aab54c0d8569f3728aa5f643
3 N6ad7951d33a14d2a8914d77a24e447b4
4 N8a9f6a3e4b984f7fa608fc02695afe85
5 N94cd046184ee4b84b58eb1ffb7067d6c
6 N95273e12b8784caa84188e0b6163dd91
7 Na4efb2d6144342bd8342b91d50b57d00
8 Nb8f963ab272549cd870edd180b13cefb
9 Nc592b52e1c7349cb988a16a70ac28f12
10 Ncbb1ab22ab6f4eec83c43bab37258dc8
11 Nd05869d995a8424bb16e4813c766ebef
12 Ne7df4f3171254de7b248cbc6711b4382
13 anzsrc-for:11
14 anzsrc-for:1112
15 schema:author Nd2595afda0b04678a6f1da66b1b1ee90
16 schema:citation sg:pub.10.1007/s12185-009-0480-5
17 sg:pub.10.1007/s12185-010-0573-1
18 sg:pub.10.1038/leu.2008.8
19 sg:pub.10.1038/modpathol.3800168
20 sg:pub.10.1038/sj.leu.2402465
21 sg:pub.10.1038/sj.leu.2403010
22 sg:pub.10.1038/sj.leu.2403838
23 https://app.dimensions.ai/details/publication/pub.1074362860
24 https://app.dimensions.ai/details/publication/pub.1074507000
25 https://app.dimensions.ai/details/publication/pub.1074525596
26 https://app.dimensions.ai/details/publication/pub.1082668270
27 https://app.dimensions.ai/details/publication/pub.1083319627
28 https://doi.org/10.1002/cncr.21493
29 https://doi.org/10.1016/j.bbrc.2008.04.065
30 https://doi.org/10.1016/j.leukres.2005.12.012
31 https://doi.org/10.1016/s0145-2126(98)00105-2
32 https://doi.org/10.1056/nejmoa041974
33 https://doi.org/10.1056/nejmoa074306
34 https://doi.org/10.1080/01621459.1958.10501452
35 https://doi.org/10.1128/mcb.15.4.1974
36 https://doi.org/10.1182/blood-2002-03-0990
37 https://doi.org/10.1182/blood-2005-05-2174
38 https://doi.org/10.1182/blood-2005-06-2248
39 https://doi.org/10.1182/blood-2008-09-179895
40 https://doi.org/10.1182/blood-2010-02-270181
41 https://doi.org/10.1182/blood-2010-03-273243
42 https://doi.org/10.1182/blood.v99.4.1332
43 https://doi.org/10.1200/jco.2008.21.6010
44 https://doi.org/10.7326/0003-4819-103-4-620
45 schema:datePublished 2011-07
46 schema:datePublishedReg 2011-07-01
47 schema:description The percentage of myeloperoxidase (MPO)-positive blast cells is a simple and highly significant prognostic factor in AML patients. It has been reported that the high MPO group (MPO-H), in which >50% of blasts are MPO activity positive, is associated with favorable karyotypes, while the low MPO group (≤50% of blasts are MPO activity positive, MPO-L) is associated with adverse karyotypes. The MPO-H group shows better survival even when restricted to patients belonging to the intermediate chromosomal risk group or those with a normal karyotype. It has recently been shown that genotypes defined by the mutational status of NPM1, FLT3, and CEBPA are associated with treatment outcome in patients with cytogenetically normal AML. In this study, we aimed to evaluate the relationship between MPO positivity and gene mutations found in normal karyotypes. Sixty AML patients with normal karyotypes were included in this study. Blast cell MPO positivity was assessed in bone marrow smears stained for MPO. Associated genetic lesions (the NPM1, FLT3-ITD, and CEBPA mutations) were studied using nucleotide sequencing. Thirty-two patients were in the MPO-L group, and 28 patients in the MPO-H group. FLT3-ITD was found in 11 patients (18.3%), NPM1 mutations were found in 19 patients (31.7%), and CEBPA mutations were found in 11 patients (18.3%). In patients with CEBPA mutations, the carrying two simultaneous mutations (CEBPA (double-mut)) was associated with high MPO expression, while the mutant NPM1 without FLT3-ITD genotype was not associated with MPO activity. Both higher MPO expression and the CEBPA (double-mut) genotype appeared to be associated with improved overall survival after intensive chemotherapy. Further studies are required to determine the importance of blast MPO activity as a prognostic factor, especially in CEBPA wild-type patients with a normal karyotype.
48 schema:genre research_article
49 schema:inLanguage en
50 schema:isAccessibleForFree true
51 schema:isPartOf N9b4426b24ca54768bcce34d1a991b27e
52 Nea1d9a3fd09546d096e9c74db246eddf
53 sg:journal.1076985
54 schema:name Expression of myeloperoxidase and gene mutations in AML patients with normal karyotype: double CEBPA mutations are associated with high percentage of MPO positivity in leukemic blasts
55 schema:pagination 81-89
56 schema:productId N8058aa8ccd70465f87466efcae81d0ee
57 N97303a0ae0b440b8a1c7fee955b88c78
58 Ndb311bd4e1b249bbbac07eb57bf40552
59 Ne466ec3743524936bab6348a9560aba9
60 Nea039864a22c4bcc8c9cfb9631cd7862
61 schema:sameAs https://app.dimensions.ai/details/publication/pub.1024091448
62 https://doi.org/10.1007/s12185-011-0883-y
63 schema:sdDatePublished 2019-04-10T15:54
64 schema:sdLicense https://scigraph.springernature.com/explorer/license/
65 schema:sdPublisher N8531182609084bdabc8b6d86e299480c
66 schema:url http://link.springer.com/10.1007%2Fs12185-011-0883-y
67 sgo:license sg:explorer/license/
68 sgo:sdDataset articles
69 rdf:type schema:ScholarlyArticle
70 N12a534ef596340bd8eaaab2c58992ab6 rdf:first sg:person.01221607161.35
71 rdf:rest N5936ac0db30547b1889109b9aa0f3084
72 N3f783410034640beb70c230f9374bfd2 rdf:first sg:person.0673127034.00
73 rdf:rest Na99d15283f714cfab41e823ea8e9c047
74 N4478a5b054bd4f42b37c47b5e06131fb schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
75 schema:name Genes, Neoplasm
76 rdf:type schema:DefinedTerm
77 N4858a85caadf4d8b84b121d94a16035e rdf:first sg:person.012267426162.55
78 rdf:rest rdf:nil
79 N4c830b2aa0b64707b23d137e6db75210 schema:name Department of Internal Medicine, Nagasaki National Medical Center, Ohmura, Nagasaki, Japan
80 rdf:type schema:Organization
81 N529114ea4ccc4dcd9365155fa3cc4309 rdf:first sg:person.0632143365.98
82 rdf:rest N7c1431c5580e423e943cbb173ed7eb82
83 N583bb765ef6d49c683a1fc1f5f152b37 rdf:first sg:person.01106224616.45
84 rdf:rest Nc8eef747124a4c8987b81229bf87c475
85 N5936ac0db30547b1889109b9aa0f3084 rdf:first sg:person.0700256565.36
86 rdf:rest N3f783410034640beb70c230f9374bfd2
87 N6089f119aab54c0d8569f3728aa5f643 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
88 schema:name Peroxidase
89 rdf:type schema:DefinedTerm
90 N6111ac40f4d4493b9b4689bde4e4778b schema:name Department of Hematology, Japanese Red-Cross Nagasaki Atomic Bomb Hospital, Nagasaki, Nagasaki, Japan
91 rdf:type schema:Organization
92 N6ad7951d33a14d2a8914d77a24e447b4 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
93 schema:name Humans
94 rdf:type schema:DefinedTerm
95 N7c1431c5580e423e943cbb173ed7eb82 rdf:first sg:person.0664421234.93
96 rdf:rest N12a534ef596340bd8eaaab2c58992ab6
97 N7da31c6f7288439b940508b5f9b331d1 schema:name Department of Internal Medicine, Nagasaki National Medical Center, Ohmura, Nagasaki, Japan
98 rdf:type schema:Organization
99 N8058aa8ccd70465f87466efcae81d0ee schema:name nlm_unique_id
100 schema:value 9111627
101 rdf:type schema:PropertyValue
102 N8442a9589b574b76920de7b59c2a20a1 rdf:first sg:person.01354366606.35
103 rdf:rest Nfc213dd6e9254d2f98e7736699978f5f
104 N8531182609084bdabc8b6d86e299480c schema:name Springer Nature - SN SciGraph project
105 rdf:type schema:Organization
106 N8a9f6a3e4b984f7fa608fc02695afe85 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
107 schema:name Survival Rate
108 rdf:type schema:DefinedTerm
109 N94cd046184ee4b84b58eb1ffb7067d6c schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
110 schema:name Leukemia, Myeloid, Acute
111 rdf:type schema:DefinedTerm
112 N95273e12b8784caa84188e0b6163dd91 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
113 schema:name Mutation
114 rdf:type schema:DefinedTerm
115 N9723183ffe0846c99fe429a780762bad rdf:first sg:person.01227410302.05
116 rdf:rest N583bb765ef6d49c683a1fc1f5f152b37
117 N97303a0ae0b440b8a1c7fee955b88c78 schema:name pubmed_id
118 schema:value 21674360
119 rdf:type schema:PropertyValue
120 N9b4426b24ca54768bcce34d1a991b27e schema:issueNumber 1
121 rdf:type schema:PublicationIssue
122 Na4efb2d6144342bd8342b91d50b57d00 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
123 schema:name fms-Like Tyrosine Kinase 3
124 rdf:type schema:DefinedTerm
125 Na99d15283f714cfab41e823ea8e9c047 rdf:first sg:person.0651002670.18
126 rdf:rest N8442a9589b574b76920de7b59c2a20a1
127 Nb568c6c2688d412f8cc26fe874a3cf2f rdf:first sg:person.0740307166.37
128 rdf:rest N4858a85caadf4d8b84b121d94a16035e
129 Nb8f963ab272549cd870edd180b13cefb schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
130 schema:name Gene Expression Regulation, Leukemic
131 rdf:type schema:DefinedTerm
132 Nc592b52e1c7349cb988a16a70ac28f12 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
133 schema:name Blast Crisis
134 rdf:type schema:DefinedTerm
135 Nc8eef747124a4c8987b81229bf87c475 rdf:first sg:person.0776410617.00
136 rdf:rest Nb568c6c2688d412f8cc26fe874a3cf2f
137 Ncbb1ab22ab6f4eec83c43bab37258dc8 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
138 schema:name Nuclear Proteins
139 rdf:type schema:DefinedTerm
140 Nd05869d995a8424bb16e4813c766ebef schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
141 schema:name CCAAT-Enhancer-Binding Proteins
142 rdf:type schema:DefinedTerm
143 Nd2595afda0b04678a6f1da66b1b1ee90 rdf:first sg:person.01260160370.57
144 rdf:rest N529114ea4ccc4dcd9365155fa3cc4309
145 Ndb311bd4e1b249bbbac07eb57bf40552 schema:name doi
146 schema:value 10.1007/s12185-011-0883-y
147 rdf:type schema:PropertyValue
148 Ne033275248564bb297d42a30071af679 rdf:first sg:person.01014505165.38
149 rdf:rest N9723183ffe0846c99fe429a780762bad
150 Ne466ec3743524936bab6348a9560aba9 schema:name dimensions_id
151 schema:value pub.1024091448
152 rdf:type schema:PropertyValue
153 Ne7df4f3171254de7b248cbc6711b4382 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
154 schema:name Karyotype
155 rdf:type schema:DefinedTerm
156 Nea039864a22c4bcc8c9cfb9631cd7862 schema:name readcube_id
157 schema:value 72c6dff3fa877e8c622cbbaecdcc5f7143bcb5731d4b4c5c52b98d7fea2d0606
158 rdf:type schema:PropertyValue
159 Nea1d9a3fd09546d096e9c74db246eddf schema:volumeNumber 94
160 rdf:type schema:PublicationVolume
161 Nf32eaa676c064d0586c156cf8510abe5 rdf:first sg:person.014677655512.53
162 rdf:rest Ne033275248564bb297d42a30071af679
163 Nfc213dd6e9254d2f98e7736699978f5f rdf:first sg:person.01231324634.52
164 rdf:rest Nf32eaa676c064d0586c156cf8510abe5
165 anzsrc-for:11 schema:inDefinedTermSet anzsrc-for:
166 schema:name Medical and Health Sciences
167 rdf:type schema:DefinedTerm
168 anzsrc-for:1112 schema:inDefinedTermSet anzsrc-for:
169 schema:name Oncology and Carcinogenesis
170 rdf:type schema:DefinedTerm
171 sg:grant.6040812 http://pending.schema.org/fundedItem sg:pub.10.1007/s12185-011-0883-y
172 rdf:type schema:MonetaryGrant
173 sg:journal.1076985 schema:issn 0925-5710
174 1865-3774
175 schema:name International Journal of Hematology
176 rdf:type schema:Periodical
177 sg:person.01014505165.38 schema:affiliation https://www.grid.ac/institutes/grid.411873.8
178 schema:familyName Hata
179 schema:givenName Tomoko
180 schema:sameAs https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01014505165.38
181 rdf:type schema:Person
182 sg:person.01106224616.45 schema:affiliation https://www.grid.ac/institutes/grid.267625.2
183 schema:familyName Kuriyama
184 schema:givenName Kazutaka
185 schema:sameAs https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01106224616.45
186 rdf:type schema:Person
187 sg:person.01221607161.35 schema:affiliation https://www.grid.ac/institutes/grid.174567.6
188 schema:familyName Itonaga
189 schema:givenName Hidehiro
190 schema:sameAs https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01221607161.35
191 rdf:type schema:Person
192 sg:person.012267426162.55 schema:affiliation https://www.grid.ac/institutes/grid.174567.6
193 schema:familyName Miyazaki
194 schema:givenName Yasushi
195 schema:sameAs https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.012267426162.55
196 rdf:type schema:Person
197 sg:person.01227410302.05 schema:affiliation https://www.grid.ac/institutes/grid.415288.2
198 schema:familyName Moriuchi
199 schema:givenName Yukiyoshi
200 schema:sameAs https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01227410302.05
201 rdf:type schema:Person
202 sg:person.01231324634.52 schema:affiliation https://www.grid.ac/institutes/grid.411873.8
203 schema:familyName Fukushima
204 schema:givenName Takuya
205 schema:sameAs https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01231324634.52
206 rdf:type schema:Person
207 sg:person.01260160370.57 schema:affiliation https://www.grid.ac/institutes/grid.174567.6
208 schema:familyName Tominaga-Sato
209 schema:givenName Shinya
210 schema:sameAs https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01260160370.57
211 rdf:type schema:Person
212 sg:person.01354366606.35 schema:affiliation https://www.grid.ac/institutes/grid.174567.6
213 schema:familyName Taguchi
214 schema:givenName Jun
215 schema:sameAs https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01354366606.35
216 rdf:type schema:Person
217 sg:person.014677655512.53 schema:affiliation N4c830b2aa0b64707b23d137e6db75210
218 schema:familyName Yoshida
219 schema:givenName Shinichiro
220 schema:sameAs https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.014677655512.53
221 rdf:type schema:Person
222 sg:person.0632143365.98 schema:affiliation https://www.grid.ac/institutes/grid.411873.8
223 schema:familyName Tsushima
224 schema:givenName Hideki
225 schema:sameAs https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.0632143365.98
226 rdf:type schema:Person
227 sg:person.0651002670.18 schema:affiliation https://www.grid.ac/institutes/grid.174567.6
228 schema:familyName Iwanaga
229 schema:givenName Masako
230 schema:sameAs https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.0651002670.18
231 rdf:type schema:Person
232 sg:person.0664421234.93 schema:affiliation N7da31c6f7288439b940508b5f9b331d1
233 schema:familyName Ando
234 schema:givenName Koji
235 schema:sameAs https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.0664421234.93
236 rdf:type schema:Person
237 sg:person.0673127034.00 schema:affiliation https://www.grid.ac/institutes/grid.411873.8
238 schema:familyName Imanishi
239 schema:givenName Daisuke
240 schema:sameAs https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.0673127034.00
241 rdf:type schema:Person
242 sg:person.0700256565.36 schema:affiliation https://www.grid.ac/institutes/grid.411873.8
243 schema:familyName Imaizumi
244 schema:givenName Yoshitaka
245 schema:sameAs https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.0700256565.36
246 rdf:type schema:Person
247 sg:person.0740307166.37 schema:affiliation N6111ac40f4d4493b9b4689bde4e4778b
248 schema:familyName Tomonaga
249 schema:givenName Masao
250 schema:sameAs https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.0740307166.37
251 rdf:type schema:Person
252 sg:person.0776410617.00 schema:affiliation https://www.grid.ac/institutes/grid.410804.9
253 schema:familyName Mano
254 schema:givenName Hiroyuki
255 schema:sameAs https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.0776410617.00
256 rdf:type schema:Person
257 sg:pub.10.1007/s12185-009-0480-5 schema:sameAs https://app.dimensions.ai/details/publication/pub.1000301266
258 https://doi.org/10.1007/s12185-009-0480-5
259 rdf:type schema:CreativeWork
260 sg:pub.10.1007/s12185-010-0573-1 schema:sameAs https://app.dimensions.ai/details/publication/pub.1047743690
261 https://doi.org/10.1007/s12185-010-0573-1
262 rdf:type schema:CreativeWork
263 sg:pub.10.1038/leu.2008.8 schema:sameAs https://app.dimensions.ai/details/publication/pub.1053611084
264 https://doi.org/10.1038/leu.2008.8
265 rdf:type schema:CreativeWork
266 sg:pub.10.1038/modpathol.3800168 schema:sameAs https://app.dimensions.ai/details/publication/pub.1016213372
267 https://doi.org/10.1038/modpathol.3800168
268 rdf:type schema:CreativeWork
269 sg:pub.10.1038/sj.leu.2402465 schema:sameAs https://app.dimensions.ai/details/publication/pub.1010409391
270 https://doi.org/10.1038/sj.leu.2402465
271 rdf:type schema:CreativeWork
272 sg:pub.10.1038/sj.leu.2403010 schema:sameAs https://app.dimensions.ai/details/publication/pub.1014114804
273 https://doi.org/10.1038/sj.leu.2403010
274 rdf:type schema:CreativeWork
275 sg:pub.10.1038/sj.leu.2403838 schema:sameAs https://app.dimensions.ai/details/publication/pub.1049352910
276 https://doi.org/10.1038/sj.leu.2403838
277 rdf:type schema:CreativeWork
278 https://app.dimensions.ai/details/publication/pub.1074362860 schema:CreativeWork
279 https://app.dimensions.ai/details/publication/pub.1074507000 schema:CreativeWork
280 https://app.dimensions.ai/details/publication/pub.1074525596 schema:CreativeWork
281 https://app.dimensions.ai/details/publication/pub.1082668270 schema:CreativeWork
282 https://app.dimensions.ai/details/publication/pub.1083319627 schema:CreativeWork
283 https://doi.org/10.1002/cncr.21493 schema:sameAs https://app.dimensions.ai/details/publication/pub.1039706671
284 rdf:type schema:CreativeWork
285 https://doi.org/10.1016/j.bbrc.2008.04.065 schema:sameAs https://app.dimensions.ai/details/publication/pub.1021924180
286 rdf:type schema:CreativeWork
287 https://doi.org/10.1016/j.leukres.2005.12.012 schema:sameAs https://app.dimensions.ai/details/publication/pub.1006793816
288 rdf:type schema:CreativeWork
289 https://doi.org/10.1016/s0145-2126(98)00105-2 schema:sameAs https://app.dimensions.ai/details/publication/pub.1000694444
290 rdf:type schema:CreativeWork
291 https://doi.org/10.1056/nejmoa041974 schema:sameAs https://app.dimensions.ai/details/publication/pub.1020502159
292 rdf:type schema:CreativeWork
293 https://doi.org/10.1056/nejmoa074306 schema:sameAs https://app.dimensions.ai/details/publication/pub.1013947506
294 rdf:type schema:CreativeWork
295 https://doi.org/10.1080/01621459.1958.10501452 schema:sameAs https://app.dimensions.ai/details/publication/pub.1058299418
296 rdf:type schema:CreativeWork
297 https://doi.org/10.1128/mcb.15.4.1974 schema:sameAs https://app.dimensions.ai/details/publication/pub.1028775369
298 rdf:type schema:CreativeWork
299 https://doi.org/10.1182/blood-2002-03-0990 schema:sameAs https://app.dimensions.ai/details/publication/pub.1008614109
300 rdf:type schema:CreativeWork
301 https://doi.org/10.1182/blood-2005-05-2174 schema:sameAs https://app.dimensions.ai/details/publication/pub.1022325658
302 rdf:type schema:CreativeWork
303 https://doi.org/10.1182/blood-2005-06-2248 schema:sameAs https://app.dimensions.ai/details/publication/pub.1036438078
304 rdf:type schema:CreativeWork
305 https://doi.org/10.1182/blood-2008-09-179895 schema:sameAs https://app.dimensions.ai/details/publication/pub.1033351081
306 rdf:type schema:CreativeWork
307 https://doi.org/10.1182/blood-2010-02-270181 schema:sameAs https://app.dimensions.ai/details/publication/pub.1022326233
308 rdf:type schema:CreativeWork
309 https://doi.org/10.1182/blood-2010-03-273243 schema:sameAs https://app.dimensions.ai/details/publication/pub.1030943868
310 rdf:type schema:CreativeWork
311 https://doi.org/10.1182/blood.v99.4.1332 schema:sameAs https://app.dimensions.ai/details/publication/pub.1052118597
312 rdf:type schema:CreativeWork
313 https://doi.org/10.1200/jco.2008.21.6010 schema:sameAs https://app.dimensions.ai/details/publication/pub.1042759768
314 rdf:type schema:CreativeWork
315 https://doi.org/10.7326/0003-4819-103-4-620 schema:sameAs https://app.dimensions.ai/details/publication/pub.1073690404
316 rdf:type schema:CreativeWork
317 https://www.grid.ac/institutes/grid.174567.6 schema:alternateName Nagasaki University
318 schema:name Department of Hematology and Molecular Medicine Unit, Atomic Bomb Disease Institute, Nagasaki University Graduate School of Biomedical Sciences, Nagasaki, Nagasaki, Japan
319 rdf:type schema:Organization
320 https://www.grid.ac/institutes/grid.267625.2 schema:alternateName University of the Ryukyus
321 schema:name School of Health Sciences, University of the Ryukyus, Okinawa, Nishihara, Japan
322 rdf:type schema:Organization
323 https://www.grid.ac/institutes/grid.410804.9 schema:alternateName Jichi Medical University
324 schema:name Division of Functional Genomics, Jichi Medical University, Shimotsuke, Tochigi, Japan
325 rdf:type schema:Organization
326 https://www.grid.ac/institutes/grid.411873.8 schema:alternateName Nagasaki University Hospital
327 schema:name Department of Hematology, Nagasaki University Hospital, 1-7-1 Sakamoto, 852-8501, Nagasaki, Japan
328 rdf:type schema:Organization
329 https://www.grid.ac/institutes/grid.415288.2 schema:alternateName Sasebo City General Hospital
330 schema:name Division of Hematology, Sasebo City General Hospital, Sasebo, Nagasaki, Japan
331 rdf:type schema:Organization
 




Preview window. Press ESC to close (or click here)


...